Books on the topic 'Antitubercular'

Deloitte & Touche. Department for International Development, Zambia health and population sector aid: Report on distribution audits, destination checks, and usage assessment for TB drugs. Lusaka]: Deloitte Touche Tohmatsu, 2000.

Wiegandt, Axel. Framework to address multi-drug-resistant TB in the Pacific island countries and territories. Noumea, New Caledonia: Secretariat of the Pacific community, 2010.

Antituberculosis chemotherapy. Basel: Karger, 2011.

Crofton, John Wenman. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

Canada, Canada Health. Tuberculosis: Drug resistance in Canada, 2003 : reported susceptibility results of the Canadian Tuberculosis Laboratory Surveillance System. [Ottawa]: Health Canada, 2004.

World Health Organization (WHO). Treatment of tuberculosis: Guidelines. 4th ed. Geneva: World Health Organization, 2010.

Nguy, Shui. Drug-resistant tuberculosis: Causes, diagnosis, and treatments. Edited by K'ung Zhou. Hauppauge NY: Nova Science Publishers, 2009.

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2009.

McHugh, Timothy D. Tuberculosis: Laboratory diagnosis and treatment strategies. Oxfordshire: CAB International, 2013.

The global threat of drug-resistant TB: A call to action for World TB Day : briefing and hearing before the Subcommittee on Africa and Global Health of the Committee on Foreign Affairs, House of Representatives, One Hundred Tenth Congress, first session, March 21, 2007. Washington: U.S. G.P.O., 2007.

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation and Rossiĭskai︠a︡ akademii︠a︡ medit︠s︡inskikh nauk, eds. The new profile of drug-resistant tuberculosis in Russia: A global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, D.C: National Academies Press, 2011.

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, ed. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge : workshop summary. Washington, D.C: National Academies Press, 2009.

Tuberculosis. Santa Barbara, Calif: Greenwood Press, 2010.

Falzon, Dennis. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization, 2009.

Experiment eleven: Deceit and betrayal in the discovery of the cure for tuberculosis. London: Bloomsbury, 2012.

John, Crofton. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

Crofton, John. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

John, Crofton. Guidelines for the management of drug-resistant tuberculosis. Geneva: WHO, 1997.

Vinšová, Jarmila. Development of new MDR-tuberculosis drugs. Hauppauge, N.Y: Nova Science Publisher, 2010.

Tom, Frieden, and World Health Organization, eds. Toman's tuberculosis: Case detection, treatment, and monitoring : questions and answers. 2nd ed. Geneva: World Health Organization, 2004.

K, Bartmann, ed. Antituberculosis drugs. Berlin: Springer-Verlag, 1988.

Organization, World Health. Treatment of Tuberculosis: Guidelines for National Programmes. World Health Organization, 1993.

Organization, World Health, ed. Treatment of tuberculosis: Guidelines for national programmes. Geneva: World Health Organization, 1993.

Wang, Mu. Studies on the biosynthesis of capreomycin. 1993.

The 2006-2011 World Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations. Icon Group International, Inc., 2005.

Parker, Philip M. The 2007-2012 World Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations. ICON Group International, Inc., 2006.

W, Yew W., ed. Development of new antituberculosis drugs. New York: Nova Science Publishers, 2006.

Ahmad, Suhail, and Eiman Mokaddas. Tuberculosis and Multidrug-Resistant Tuberculosis: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies and Novel Drugs. Nova Science Publishers, Incorporated, 2013.

Parker, Philip M. The 2007-2012 Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations in Japan. ICON Group International, Inc., 2006.

Parker, Philip M. The 2007-2012 Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations in Greater China. ICON Group International, Inc., 2006.

Tuberculosis: Drug resistance in Canada : reported susceptibility results of the Canadian Tuberculosis Laboratory Surveillance System. Ottawa: Health Canada, 1999.

Parker, Philip M. The 2007-2012 Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations in the United States. ICON Group International, Inc., 2006.

Michael, Rich, and World Health Organization, eds. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2006.

Organization, World Health. WHO Model Prescribing Information. World Health Organization, 2001.

Organization, World Health, ed. WHO model prescribing information: Drugs used in mycobacterial diseases. Geneva: World Health Organization, 1991.

World Health Organization (WHO). Who Model Prescribing Information: Drugs Used in Mycobacterial Diseases. World Health Organization, 1991.

N, Rom William, and Garay Stuart M, eds. Tuberculosis. Boston: Little, Brown, 1996.

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. Geneva: World Health Organization, Stop TB Department, 2008.

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. Geneva: World Health Organization, Stop TB Department, 2008.

Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions in India - Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. National Academies Press, 2012.

B, Heifets Leonid, and Cynamon Michael H, eds. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, Fla: CRC Press, 1991.

Rom, William N., and Stuart M. Garay. Tuberculosis. 2nd ed. Lippincott Williams & Wilkins, 2003.

N, Rom William, and Garay Stuart M, eds. Tuberculosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2004.